AsclepiX Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch AsclepiX Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (nAMD) (NCT05859776) | AsclepiX Therapeutics, Inc. | 2023-12-19 |
| Safety and Bioactivity of AXT107 in Subjects With Neovascular Age-Related Macular Degeneration (NCT04746963) | AsclepiX Therapeutics, Inc. | 2021-02-01 |
| Safety and Bioactivity of AXT107 in Subjects With Diabetic Macular Edema (NCT04697758) | AsclepiX Therapeutics, Inc. | 2020-12-10 |
Track AsclepiX Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.